Mobia Medical, Inc. (NASDAQ:MOBI) Stock Short Interest Report for September

Posted by Francis Steltz on Oct 14th, 2026

Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 1,083,787 shares, a growth of 130.7% from the September 15th total of 469,701 shares. Approximately 3.3% of the shares of the company are short sold. Based on an average trading volume of 381,101 shares, the days-to-cover ratio is presently 2.8 days.

Mobia Medical Stock Down 1.6%

Shares of Mobia Medical stock traded down $0.14 on Wednesday, hitting $8.36. The stock had a trading volume of 119,192 shares, compared to its average volume of 176,636. The firm has a market capitalization of $278.30 million and a PE ratio of -0.41. The company has a current ratio of 13.28, a quick ratio of 12.80 and a debt-to-equity ratio of 0.04. Mobia Medical has a twelve month low of $8.15 and a twelve month high of $15.29. The company has a 50 day moving average price of $10.45.

Mobia Medical (NASDAQ:MOBI – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The company had revenue of $13.51 million during the quarter. The business’s revenue for the quarter was up 102.4% compared to the same quarter last year. As a group, equities analysts predict that Mobia Medical will post -2.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on MOBI shares. JPMorgan Chase & Co. upped their price objective on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. BTIG Research reaffirmed a “buy” rating and set a $19.00 target price on shares of Mobia Medical in a report on Wednesday, August 12th. Finally, Weiss Ratings assumed coverage on shares of Mobia Medical in a report on Wednesday, August 12th. They set a “sell (e-)” rating for the company. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $20.75.

Check Out Our Latest Report on MOBI

Insiders Place Their Bets

In other Mobia Medical news, Director Casey Tansey purchased 16,441 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was acquired at an average price of $12.07 per share, with a total value of $198,442.87. Following the acquisition, the director directly owned 318,332 shares of the company’s stock, valued at $3,842,267.24. This trade represents a 5.45% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In the last quarter, insiders acquired 87,000 shares of company stock valued at $1,016,367.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in MOBI. State Street Corp acquired a new stake in shares of Mobia Medical during the second quarter worth $735,000. Citadel Advisors LLC acquired a new position in shares of Mobia Medical in the second quarter valued at about $670,000. Finally, Readystate Asset Management LP acquired a new position in shares of Mobia Medical in the second quarter valued at about $134,000.

About Mobia Medical

(Get Free Report)

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.